| |
| |
|
| Insider
Information: |
Hacksell Uli |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
20,000 |
|
|
Indirect Shares
|
115,549 |
|
|
| Direct
Value |
$8,602 |
|
|
|
Indirect Value
|
$1,720,525 |
|
|
| Total
Shares |
135,549 |
|
|
| Total
Value |
$1,729,127 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
|
2015-02-17 |
0 |
2015-02-17 |
115,549 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
Director |
2017-06-09 |
20,000 |
2016-12-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2013-05-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,449 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2012-08-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
23,333 |
101,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2012-08-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,333 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2012-08-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,333 |
23,333 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2006-08-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
25,000 |
122,916 |
|
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2006-08-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
8,300 |
|
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-01-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
25,000 |
140,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-01-15 |
4 |
AS |
$24.01 |
$600,288 |
I/I |
(25,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-01-15 |
4 |
OE |
$6.95 |
$173,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-02-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
25,000 |
140,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-02-18 |
4 |
AS |
$24.14 |
$603,528 |
I/I |
(25,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-02-18 |
4 |
OE |
$6.95 |
$173,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-04-15 |
4 |
AS |
$17.75 |
$443,835 |
I/I |
(25,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-04-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-04-15 |
4 |
OE |
$6.95 |
$173,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-04-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
25,000 |
140,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
AS |
$27.36 |
$820,821 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
AS |
$24.15 |
$724,530 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
103 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
